Long-term Monitoring of Growth and Development of Pediatric Patients Previously Treated With Everolimus
Completed · Phase 4
Conditions studied: Growth and Development
In brief
The primary objective of CRAD001M2305 was to report the long-term effects of everolimus treatment on height, weight and sexual development (using Tanner Stages) in children and adolescents with Tuberous Sclerosis Complex (TSC)-associated with Subependymal Giant Cell Astrocytoma (SEGA). The study monitored the growth and development of pediatric patients with TSC-associated SEGA, previously enrolled in CRAD001M2301 (NCT00789828) until they reach Tanner Stage V, or until age 16 for females or 17 for males whichever occurred first.
Key facts
- Study ID
- NCT02338609
- Run by
- Novartis Pharmaceuticals
- People needed
- 15
- Starts
- 2014-12-17
- Expected to finish
- 2023-12-18
- Last updated by the study team
- 2024-08-09
Who can join
Age: any, up to 17. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Pediatric female patients who were on study treatment in study [CRAD001M2301] within the past 6 months and have not reached Tanner Stage V or age 16 at the time of completion of [CRAD001M2301] or
- Pediatric male patients who were on study treatment in study [CRAD001M2301] within the past 6 months and have not reached Tanner Stage V or age 17 at the time of completion of [CRAD001M2301]
- Written informed consent according to local guidelines
You may not qualify if…
- Pediatric female patients who were on study treatment in CRAD001M2301 and have not reached Tanner Stage V but are within 3 month of turning age 16 or
- Pediatric male patients who were on study treatment in CRAD001M2301 and have not reached Tanner Stage V but are within 3 months of turning age 17
- Any patient who was pregnant prior to start of CRAD001M2305
Where it is running
- University Of California LA SC — Los Angeles, California, United States
- Minnesota Epilepsy Group — Saint Paul, Minnesota, United States
- Cinn Children Hosp Medical Center SC — Cincinnati, Ohio, United States
- Texas Scottish Rite Hos for Child SC — Dallas, Texas, United States
- Novartis Investigative Site — Brussels, Belgium
- Novartis Investigative Site — Moscow, Russia
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.